Alpha-1-antitrypsin augmentation treatment: does one size fit all? (Q42764419)

6 November 2017

0 references

Alpha-1-antitrypsin augmentation treatment: does one size fit all? (English)

1 reference

6 November 2017

Stolk J

1

1 reference

PMCID

2117068

6 November 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

6 November 2017

1 reference

6 November 2017

61

1 reference

6 November 2017

1034

1 reference

6 November 2017

12

1 reference

Alpha-1-antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokinetics

6 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117068

alpha1-Antitrypsin deficiency . 5: intravenous augmentation therapy: current understanding

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117068

Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117068

Alpha1-antitrypsin deficiency--a model for conformational diseases

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117068

Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117068

American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117068

Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117068

Experience with replacement therapy in the destructive lung disease associated with severe alpha-1-antitrypsin deficiency

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17114371

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/THX.2006.067710

1 reference

6 November 2017

1 reference

6 November 2017

1 reference

PMCID

2117068